Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.11/Share
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.11), versus ($0.18) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
- Copart launches $10.50-per-share tender offer to acquire ACV
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
